Breast cancer diagnosis: a survey of pre-processing, segmentation, feature extraction and classification

Machine learning methods have been an interesting method in the field of medical for many years, and they have achieved successful results in various fields of medical science. This paper examines the effects of using machine learning algorithms in the diagnosis and classification of breast cancer from mammography imaging data. Cancer diagnosis is the identification of images as cancer or non-cancer, and this involves image preprocessing, feature extraction, classification, and performance analysis. This article studied 93 different references mentioned in the previous years in the field of processing and tries to find an effective way to diagnose and classify breast cancer. Based on the results of this research, it can be concluded that most of today’s successful methods focus on the use of deep learning methods. Finding a new method requires an overview of existing methods in the field of deep learning methods in order to make a comparison and case study

Comparative Analysis of Segment Anything Model and U-Net for Breast Tumor Detection in Ultrasound and Mammography Images

In this study, the main objective is to develop an algorithm capable of identifying and delineating tumor regions in breast ultrasound (BUS) and mammographic images. The technique employs two advanced deep learning architectures, namely U-Net and pretrained SAM, for tumor segmentation. The U-Net model is specifically designed for medical image segmentation and leverages its deep convolutional neural network framework to extract meaningful features from input images. On the other hand, the pretrained SAM architecture incorporates a mechanism to capture spatial dependencies and generate segmentation results. Evaluation is conducted on a diverse dataset containing annotated tumor regions in BUS and mammographic images, covering both benign and malignant tumors. This dataset enables a comprehensive assessment of the algorithm's performance across different tumor types. Results demonstrate that the U-Net model outperforms the pretrained SAM architecture in accurately identifying and segmenting tumor regions in both BUS and mammographic images. The U-Net exhibits superior performance in challenging cases involving irregular shapes, indistinct boundaries, and high tumor heterogeneity. In contrast, the pretrained SAM architecture exhibits limitations in accurately identifying tumor areas, particularly for malignant tumors and objects with weak boundaries or complex shapes. These findings highlight the importance of selecting appropriate deep learning architectures tailored for medical image segmentation. The U-Net model showcases its potential as a robust and accurate tool for tumor detection, while the pretrained SAM architecture suggests the need for further improvements to enhance segmentation performance

Image processing and machine learning techniques used in computer-aided detection system for mammogram screening - a review

This paper aims to review the previously developed Computer-aided detection (CAD) systems for mammogram screening because increasing death rate in women due to breast cancer is a global medical issue and it can be controlled only by early detection with regular screening. Till now mammography is the widely used breast imaging modality. CAD systems have been adopted by the radiologists to increase the accuracy of the breast cancer diagnosis by avoiding human errors and experience related issues. This study reveals that in spite of the higher accuracy obtained by the earlier proposed CAD systems for breast cancer diagnosis, they are not fully automated. Moreover, the false-positive mammogram screening cases are high in number and over-diagnosis of breast cancer exposes a patient towards harmful overtreatment for which a huge amount of money is being wasted. In addition, it is also reported that the mammogram screening result with and without CAD systems does not have noticeable difference, whereas the undetected cancer cases by CAD system are increasing. Thus, future research is required to improve the performance of CAD system for mammogram screening and make it completely automated

A Modified LeNet CNN for Breast Cancer Diagnosis in Ultrasound Images

Convolutional neural networks (CNNs) have been extensively utilized in medical image processing to automatically extract meaningful features and classify various medical conditions, enabling faster and more accurate diagnoses. In this paper, LeNet, a classic CNN architecture, has been successfully applied to breast cancer data analysis. It demonstrates its ability to extract discriminative features and classify malignant and benign tumors with high accuracy, thereby supporting early detection and diagnosis of breast cancer. LeNet with corrected Rectified Linear Unit (ReLU), a modification of the traditional ReLU activation function, has been found to improve the performance of LeNet in breast cancer data analysis tasks via addressing the “dying ReLU” problem and enhancing the discriminative power of the extracted features. This has led to more accurate, reliable breast cancer detection and diagnosis and improved patient outcomes. Batch normalization improves the performance and training stability of small and shallow CNN architecture like LeNet. It helps to mitigate the effects of internal covariate shift, which refers to the change in the distribution of network activations during training. This classifier will lessen the overfitting problem and reduce the running time. The designed classifier is evaluated against the benchmarking deep learning models, proving that this has produced a higher recognition rate. The accuracy of the breast image recognition rate is 89.91%. This model will achieve better performance in segmentation, feature extraction, classification, and breast cancer tumor detection

Experimental Investigation for Detecting Mitotic Cells in Medical Image using an Automated Algorithm

Cancer of the breast is a malignant tumour that originates in the cells of the breast tissue. It is by far the most common kind of cancer found in females around the world, with a projected 2.3 million new cases will be discovered in the year 2020 alone. It is projected that one in eight women will be diagnosed with breast cancer at some point in their life, despite the fact that breast cancer can also occur in men. Breast cancer is a complex condition that can arise from a diverse set of factors, express itself in a variety of ways, and can be treated in a variety of ways. Ductal carcinoma in situ, invasive ductal carcinoma, and invasive lobular carcinoma are all different subtypes. Both the available treatment options and the expected outcome of breast cancer are very variable depending on the particular subtype of the illness. Breast cancer risk factors include drinking alcohol and not getting enough exercise, as well as getting older, having a family history of the disease, having genetic mutations, being exposed to estrogens, and having a family history of the disease. There is not always a connection between having risk factors and developing breast cancer, despite the fact that there can be a link between the two. The prognosis and treatment options for breast cancer are highly dependent on the stage of the disease at the time of diagnosis. During staging, the extent to which the cancer has spread throughout the body and how far it has progressed are both measured. The TNM system, the IAFCM system, the ACM system, and the MPIG system are just few of the staging systems that are used to classify breast cancer. These staging systems consider not only the size of the tumor but also whether or not lymph nodes are involved and whether or not distant metastases are present. The severity of breast cancer symptoms can vary widely, depending not only on the subtype of the disease but also on how far along it has progressed. Alterations in the size or shape of the breast, discharge from the nipple, and alterations in the skin of the breast (such as redness or dimpling) are all common indications. On the other hand, not all cases of breast cancer present themselves in a visible manner, and mammography and other forms of routine screening may be able to detect some of these cases. Options for treating breast cancer vary depending on the patient's condition and the stage of the disease, as well as the patient's overall health and their preferences towards therapy. Common examples of medical interventions include surgery, radiotherapy, chemotherapy, hormone therapy, and targeted therapy. Other examples include. In certain cases, it may be appropriate to participate in more than one form of treatment